aluates Reports

$ 0.0

Automative

Global Kidney Cancer Therapy Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-34R13395

Global Kidney Cancer Therapy Market Research Report 2023

BUY CHAPTERS

Global Kidney Cancer Therapy Market Research Report 2025

Code: QYRE-Auto-34R13395

Report

July 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Bristol–Myers Squibb

Roche

Novartis

Bayer

Merck

Exelixis Inc

Eisai Co Ltd

Amgen Inc

AVEO Pharmaceuticals

Hikma Pharmaceuticals

Sun Pharmaceutical

Kidney Cancer Therapy Market Size

The global market for Kidney Cancer Therapy was valued at US$ 11510 million in the year 2024 and is projected to reach a revised size of US$ 17550 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Kidney Cancer Therapy Market

Kidney cancer therapy refers to a range of medical treatments aimed at managing or eradicating cancerous cells in the kidneys. These treatments include surgery (such as nephrectomy), targeted therapy, immunotherapy, radiation therapy, and, in some cases, chemotherapy. The choice of therapy depends on the type, stage, and progression of the cancer, as well as the patient’s overall health. The primary goals are to control the disease, prolong survival, and improve the patient’s quality of life.

Market Drivers for Kidney Cancer Therapy

Rising Incidence of Kidney Cancer: The increasing prevalence of kidney cancer globally, fueled by aging populations and risk factors such as obesity and smoking, is driving the demand for innovative therapies.

Advancements in Therapeutics: The development of novel therapies, including targeted drugs, immunotherapies (e.g., immune checkpoint inhibitors), and personalized medicine approaches, is significantly enhancing treatment efficacy and patient outcomes.

Growing Adoption of Minimally Invasive Procedures: Techniques such as laparoscopic and robotic-assisted surgeries are gaining traction, offering improved recovery times and lower complication rates.

Supportive Healthcare Infrastructure and Policies: Governments and healthcare organizations are investing in cancer research and treatment facilities, creating favorable conditions for market growth.

Increasing Awareness and Early Detection: Greater public awareness and advancements in diagnostic tools are leading to earlier detection, boosting the demand for effective therapies.

Market Challenges for Kidney Cancer Therapy

High Cost of Advanced Therapies: The expensive nature of targeted therapies and immunotherapies makes them less accessible, particularly in low- and middle-income regions.

Therapeutic Resistance: The emergence of resistance to targeted drugs, such as tyrosine kinase inhibitors, poses significant challenges in treatment management.

Adverse Side Effects: Immunotherapies and other advanced treatments can cause severe side effects, which may limit their usage and patient compliance.

Limited Access to Healthcare in Developing Regions: Insufficient healthcare infrastructure and limited availability of cutting-edge treatments restrict market expansion in underdeveloped areas.

Regulatory and Approval Complexities: Stringent regulations and lengthy approval processes for new therapies can delay market entry and restrict innovation.

This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Therapy.

The Kidney Cancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Kidney Cancer Therapy Market Report

Report Metric	Details
Report Name	Kidney Cancer Therapy Market
Accounted market size in year	US$ 11510 million
Forecasted market size in 2031	US$ 17550 million
CAGR	6.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Surgery Immunotherapy Targeted Therapy Other
Segment by Application	Renal Cell Carcinoma (RCC) Transitional Cell Carcinoma (TCC)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai, Hikma Pharmaceuticals, Sun Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Kidney Cancer Therapy Market growing?

Ans: The Kidney Cancer Therapy Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Kidney Cancer Therapy Market size in 2031?

Ans: The Kidney Cancer Therapy Market size in 2031 will be US$ 17550 million.

Who are the main players in the Kidney Cancer Therapy Market report?

Ans: The main players in the Kidney Cancer Therapy Market are Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai, Hikma Pharmaceuticals, Sun Pharmaceutical

What are the Application segmentation covered in the Kidney Cancer Therapy Market report?

Ans: The Applications covered in the Kidney Cancer Therapy Market report are Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC)

What are the Type segmentation covered in the Kidney Cancer Therapy Market report?

Ans: The Types covered in the Kidney Cancer Therapy Market report are Surgery, Immunotherapy, Targeted Therapy, Other

Recommended Reports

Kidney Disease Management

Cancer Therapy Markets

Renal Oncology Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Kidney Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Surgery

1.2.3 Immunotherapy

1.2.4 Targeted Therapy

1.2.5 Other

1.3 Market by Application

1.3.1 Global Kidney Cancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Renal Cell Carcinoma (RCC)

1.3.3 Transitional Cell Carcinoma (TCC)

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Kidney Cancer Therapy Market Perspective (2020-2031)

2.2 Global Kidney Cancer Therapy Growth Trends by Region

2.2.1 Global Kidney Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Kidney Cancer Therapy Historic Market Size by Region (2020-2025)

2.2.3 Kidney Cancer Therapy Forecasted Market Size by Region (2026-2031)

2.3 Kidney Cancer Therapy Market Dynamics

2.3.1 Kidney Cancer Therapy Industry Trends

2.3.2 Kidney Cancer Therapy Market Drivers

2.3.3 Kidney Cancer Therapy Market Challenges

2.3.4 Kidney Cancer Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Kidney Cancer Therapy Players by Revenue

3.1.1 Global Top Kidney Cancer Therapy Players by Revenue (2020-2025)

3.1.2 Global Kidney Cancer Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Kidney Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Kidney Cancer Therapy Revenue

3.4 Global Kidney Cancer Therapy Market Concentration Ratio

3.4.1 Global Kidney Cancer Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Therapy Revenue in 2024

3.5 Global Key Players of Kidney Cancer Therapy Head office and Area Served

3.6 Global Key Players of Kidney Cancer Therapy, Product and Application

3.7 Global Key Players of Kidney Cancer Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Cancer Therapy Breakdown Data by Type

4.1 Global Kidney Cancer Therapy Historic Market Size by Type (2020-2025)

4.2 Global Kidney Cancer Therapy Forecasted Market Size by Type (2026-2031)

5 Kidney Cancer Therapy Breakdown Data by Application

5.1 Global Kidney Cancer Therapy Historic Market Size by Application (2020-2025)

5.2 Global Kidney Cancer Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Kidney Cancer Therapy Market Size (2020-2031)

6.2 North America Kidney Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Kidney Cancer Therapy Market Size by Country (2020-2025)

6.4 North America Kidney Cancer Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Kidney Cancer Therapy Market Size (2020-2031)

7.2 Europe Kidney Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Kidney Cancer Therapy Market Size by Country (2020-2025)

7.4 Europe Kidney Cancer Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Kidney Cancer Therapy Market Size (2020-2031)

8.2 Asia-Pacific Kidney Cancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Kidney Cancer Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Kidney Cancer Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Kidney Cancer Therapy Market Size (2020-2031)

9.2 Latin America Kidney Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Kidney Cancer Therapy Market Size by Country (2020-2025)

9.4 Latin America Kidney Cancer Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Kidney Cancer Therapy Market Size (2020-2031)

10.2 Middle East & Africa Kidney Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Kidney Cancer Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Kidney Cancer Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Kidney Cancer Therapy Introduction

11.1.4 Merck Revenue in Kidney Cancer Therapy Business (2020-2025)

11.1.5 Merck Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Kidney Cancer Therapy Introduction

11.2.4 Novartis Revenue in Kidney Cancer Therapy Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Kidney Cancer Therapy Introduction

11.3.4 Bristol-Myers Squibb Revenue in Kidney Cancer Therapy Business (2020-2025)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Kidney Cancer Therapy Introduction

11.4.4 Pfizer Revenue in Kidney Cancer Therapy Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Kidney Cancer Therapy Introduction

11.5.4 Roche Revenue in Kidney Cancer Therapy Business (2020-2025)

11.5.5 Roche Recent Development

11.6 Amgen

11.6.1 Amgen Company Details

11.6.2 Amgen Business Overview

11.6.3 Amgen Kidney Cancer Therapy Introduction

11.6.4 Amgen Revenue in Kidney Cancer Therapy Business (2020-2025)

11.6.5 Amgen Recent Development

11.7 Aveo Pharmaceuticals

11.7.1 Aveo Pharmaceuticals Company Details

11.7.2 Aveo Pharmaceuticals Business Overview

11.7.3 Aveo Pharmaceuticals Kidney Cancer Therapy Introduction

11.7.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Therapy Business (2020-2025)

11.7.5 Aveo Pharmaceuticals Recent Development

11.8 Bayer

11.8.1 Bayer Company Details

11.8.2 Bayer Business Overview

11.8.3 Bayer Kidney Cancer Therapy Introduction

11.8.4 Bayer Revenue in Kidney Cancer Therapy Business (2020-2025)

11.8.5 Bayer Recent Development

11.9 Exelixis

11.9.1 Exelixis Company Details

11.9.2 Exelixis Business Overview

11.9.3 Exelixis Kidney Cancer Therapy Introduction

11.9.4 Exelixis Revenue in Kidney Cancer Therapy Business (2020-2025)

11.9.5 Exelixis Recent Development

11.10 Eisai

11.10.1 Eisai Company Details

11.10.2 Eisai Business Overview

11.10.3 Eisai Kidney Cancer Therapy Introduction

11.10.4 Eisai Revenue in Kidney Cancer Therapy Business (2020-2025)

11.10.5 Eisai Recent Development

11.11 Hikma Pharmaceuticals

11.11.1 Hikma Pharmaceuticals Company Details

11.11.2 Hikma Pharmaceuticals Business Overview

11.11.3 Hikma Pharmaceuticals Kidney Cancer Therapy Introduction

11.11.4 Hikma Pharmaceuticals Revenue in Kidney Cancer Therapy Business (2020-2025)

11.11.5 Hikma Pharmaceuticals Recent Development

11.12 Sun Pharmaceutical

11.12.1 Sun Pharmaceutical Company Details

11.12.2 Sun Pharmaceutical Business Overview

11.12.3 Sun Pharmaceutical Kidney Cancer Therapy Introduction

11.12.4 Sun Pharmaceutical Revenue in Kidney Cancer Therapy Business (2020-2025)

11.12.5 Sun Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Bristol–Myers Squibb

Roche

Novartis

Bayer

Merck

Exelixis Inc

Eisai Co Ltd

Amgen Inc

AVEO Pharmaceuticals

Hikma Pharmaceuticals

Sun Pharmaceutical

List of Tables

Table 1. Global Kidney Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Surgery

Table 3. Key Players of Immunotherapy

Table 4. Key Players of Targeted Therapy

Table 5. Key Players of Other

Table 6. Global Kidney Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Kidney Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Kidney Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Kidney Cancer Therapy Market Share by Region (2020-2025)

Table 10. Global Kidney Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Kidney Cancer Therapy Market Share by Region (2026-2031)

Table 12. Kidney Cancer Therapy Market Trends

Table 13. Kidney Cancer Therapy Market Drivers

Table 14. Kidney Cancer Therapy Market Challenges

Table 15. Kidney Cancer Therapy Market Restraints

Table 16. Global Kidney Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Kidney Cancer Therapy Market Share by Players (2020-2025)

Table 18. Global Top Kidney Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapy as of 2024)

Table 19. Ranking of Global Top Kidney Cancer Therapy Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Kidney Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Kidney Cancer Therapy, Headquarters and Area Served

Table 22. Global Key Players of Kidney Cancer Therapy, Product and Application

Table 23. Global Key Players of Kidney Cancer Therapy, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Kidney Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Kidney Cancer Therapy Revenue Market Share by Type (2020-2025)

Table 27. Global Kidney Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Kidney Cancer Therapy Revenue Market Share by Type (2026-2031)

Table 29. Global Kidney Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Kidney Cancer Therapy Revenue Market Share by Application (2020-2025)

Table 31. Global Kidney Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Kidney Cancer Therapy Revenue Market Share by Application (2026-2031)

Table 33. North America Kidney Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Kidney Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Kidney Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Kidney Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Kidney Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Kidney Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Kidney Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Kidney Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Kidney Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Kidney Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Kidney Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Kidney Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Kidney Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Kidney Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Kidney Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 48. Merck Company Details

Table 49. Merck Business Overview

Table 50. Merck Kidney Cancer Therapy Product

Table 51. Merck Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 52. Merck Recent Development

Table 53. Novartis Company Details

Table 54. Novartis Business Overview

Table 55. Novartis Kidney Cancer Therapy Product

Table 56. Novartis Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 57. Novartis Recent Development

Table 58. Bristol-Myers Squibb Company Details

Table 59. Bristol-Myers Squibb Business Overview

Table 60. Bristol-Myers Squibb Kidney Cancer Therapy Product

Table 61. Bristol-Myers Squibb Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 62. Bristol-Myers Squibb Recent Development

Table 63. Pfizer Company Details

Table 64. Pfizer Business Overview

Table 65. Pfizer Kidney Cancer Therapy Product

Table 66. Pfizer Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 67. Pfizer Recent Development

Table 68. Roche Company Details

Table 69. Roche Business Overview

Table 70. Roche Kidney Cancer Therapy Product

Table 71. Roche Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 72. Roche Recent Development

Table 73. Amgen Company Details

Table 74. Amgen Business Overview

Table 75. Amgen Kidney Cancer Therapy Product

Table 76. Amgen Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 77. Amgen Recent Development

Table 78. Aveo Pharmaceuticals Company Details

Table 79. Aveo Pharmaceuticals Business Overview

Table 80. Aveo Pharmaceuticals Kidney Cancer Therapy Product

Table 81. Aveo Pharmaceuticals Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 82. Aveo Pharmaceuticals Recent Development

Table 83. Bayer Company Details

Table 84. Bayer Business Overview

Table 85. Bayer Kidney Cancer Therapy Product

Table 86. Bayer Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 87. Bayer Recent Development

Table 88. Exelixis Company Details

Table 89. Exelixis Business Overview

Table 90. Exelixis Kidney Cancer Therapy Product

Table 91. Exelixis Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 92. Exelixis Recent Development

Table 93. Eisai Company Details

Table 94. Eisai Business Overview

Table 95. Eisai Kidney Cancer Therapy Product

Table 96. Eisai Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 97. Eisai Recent Development

Table 98. Hikma Pharmaceuticals Company Details

Table 99. Hikma Pharmaceuticals Business Overview

Table 100. Hikma Pharmaceuticals Kidney Cancer Therapy Product

Table 101. Hikma Pharmaceuticals Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 102. Hikma Pharmaceuticals Recent Development

Table 103. Sun Pharmaceutical Company Details

Table 104. Sun Pharmaceutical Business Overview

Table 105. Sun Pharmaceutical Kidney Cancer Therapy Product

Table 106. Sun Pharmaceutical Revenue in Kidney Cancer Therapy Business (2020-2025) & (US$ Million)

Table 107. Sun Pharmaceutical Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Kidney Cancer Therapy Picture

Figure 2. Global Kidney Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Kidney Cancer Therapy Market Share by Type: 2024 VS 2031

Figure 4. Surgery Features

Figure 5. Immunotherapy Features

Figure 6. Targeted Therapy Features

Figure 7. Other Features

Figure 8. Global Kidney Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Kidney Cancer Therapy Market Share by Application: 2024 VS 2031

Figure 10. Renal Cell Carcinoma (RCC) Case Studies

Figure 11. Transitional Cell Carcinoma (TCC) Case Studies

Figure 12. Kidney Cancer Therapy Report Years Considered

Figure 13. Global Kidney Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Kidney Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Kidney Cancer Therapy Market Share by Region: 2024 VS 2031

Figure 16. Global Kidney Cancer Therapy Market Share by Players in 2024

Figure 17. Global Top Kidney Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapy as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Kidney Cancer Therapy Revenue in 2024

Figure 19. North America Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Kidney Cancer Therapy Market Share by Country (2020-2031)

Figure 21. United States Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Kidney Cancer Therapy Market Share by Country (2020-2031)

Figure 25. Germany Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Kidney Cancer Therapy Market Share by Region (2020-2031)

Figure 33. China Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Kidney Cancer Therapy Market Share by Country (2020-2031)

Figure 41. Mexico Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Kidney Cancer Therapy Market Share by Country (2020-2031)

Figure 45. Turkey Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Kidney Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Merck Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 49. Novartis Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 53. Amgen Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 54. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 55. Bayer Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 56. Exelixis Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 57. Eisai Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 58. Hikma Pharmaceuticals Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 59. Sun Pharmaceutical Revenue Growth Rate in Kidney Cancer Therapy Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cancer Drug Therapy Market Insights Forecast to 2030

Global Kidney Cancer Therapeutics and Diagnostics Market Insights Forecast to 2030

Renal Cell Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kidney Cancer Therapeutics Market Research Report 2025

Global Kidney Cancer Drugs Market Research Report 2024

Global Kidney Cancer Targeted Therapy Market Research Report 2025

Renal Cell Carcinoma Therapy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Kidney Cancer Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kidney Cancer or Renal Cancer Market Research Report 2024

Global Kidney Cancer and Renal Cell Carcinoma RCC Drugs Market Insights Forecast to 2030

Kidney Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global End stage Renal Disease Therapeutics Market Research Report 2024

Global Urological Cancer Therapeutics Drugs Market Research Report 2024

Genitourinary Cancers Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Renal Therapeutic Market Research Report 2025

Global Late Stage Chronic Kidney Disease Therapeutics Market Research Report 2024

Global Cancer Targeted Drug Market Research Report 2025

Advanced Renal Cell Carcinoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4H16852

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K16619

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30U16301

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2G16953

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions